Поиск :
Личный кабинет :
Электронный каталог: Kostelnik, T. I. - Production and Radiochemistry of Antimony-120m: Efforts Toward Auger Electron Therapy with *1*1*9Sb
Kostelnik, T. I. - Production and Radiochemistry of Antimony-120m: Efforts Toward Auger Electron Therapy with *1*1*9Sb
Статья
Автор: Kostelnik, T. I.
Nuclear Medicine and Biology [Electronic resource]: Production and Radiochemistry of Antimony-120m: Efforts Toward Auger Electron Therapy with *1*1*9Sb
б.г.
ISBN отсутствует
Автор: Kostelnik, T. I.
Nuclear Medicine and Biology [Electronic resource]: Production and Radiochemistry of Antimony-120m: Efforts Toward Auger Electron Therapy with *1*1*9Sb
б.г.
ISBN отсутствует
На полку
Статья
Kostelnik, T.I.
Production and Radiochemistry of Antimony-120m: Efforts Toward Auger Electron Therapy with *1*1*9Sb / T.I.Kostelnik, A.Marinova, D.Karaivanov, D.Filosofov, [et al.] // Nuclear Medicine and Biology [Electronic resource]. – 2023. – Vol.122-123. – P.108352. – URL: https://doi.org/10.1016/j.nucmedbio.2023.108352. – Bibliogr.:37.
Targeted Meitner-Auger Therapy (TMAT) has potential for personalized treatment thanks to its subcellular dosimetric selectivity, which is distinct from the dosimetry of β− and α particle emission based Targeted Radionuclide Therapy (TRT). To date, most clinical and preclinical TMAT studies have used commercially available radionuclides. These studies showed promising results despite using radionuclides with theoretically suboptimal photon to electron ratios, decay kinetics, and electron emission spectra. Studies using radionuclides whose decay characteristics are considered more optimal are therefore important for evaluation of the full potential of Meitner-Auger therapy; 119Sb is among the best such candidates. In the present work, we develop radiochemical purification of 120Sb from irradiated natural tin targets for TMAT studies with 119Sb.
ОИЯИ = ОИЯИ (JINR)2023
Спец.(статьи,препринты) = С 349 д - Биологическое действие излучений$
Бюллетени = 5/024
Kostelnik, T.I.
Production and Radiochemistry of Antimony-120m: Efforts Toward Auger Electron Therapy with *1*1*9Sb / T.I.Kostelnik, A.Marinova, D.Karaivanov, D.Filosofov, [et al.] // Nuclear Medicine and Biology [Electronic resource]. – 2023. – Vol.122-123. – P.108352. – URL: https://doi.org/10.1016/j.nucmedbio.2023.108352. – Bibliogr.:37.
Targeted Meitner-Auger Therapy (TMAT) has potential for personalized treatment thanks to its subcellular dosimetric selectivity, which is distinct from the dosimetry of β− and α particle emission based Targeted Radionuclide Therapy (TRT). To date, most clinical and preclinical TMAT studies have used commercially available radionuclides. These studies showed promising results despite using radionuclides with theoretically suboptimal photon to electron ratios, decay kinetics, and electron emission spectra. Studies using radionuclides whose decay characteristics are considered more optimal are therefore important for evaluation of the full potential of Meitner-Auger therapy; 119Sb is among the best such candidates. In the present work, we develop radiochemical purification of 120Sb from irradiated natural tin targets for TMAT studies with 119Sb.
ОИЯИ = ОИЯИ (JINR)2023
Спец.(статьи,препринты) = С 349 д - Биологическое действие излучений$
Бюллетени = 5/024
Привязано к:
Нет экз.